GLUL and in situ carcinoma: As observed in mice with MSO-induced depression, CIS-treated mice also exhibited low Glu–Gln levels, decreased GS activity without a change in expression level, and reduced sEPSC frequency in glutamatergic neurons within the mPFC accompanied by depressive behaviors.